Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody

DBCAT003282Therapeutic category

A DrugBank category of 3 drugs. 3 of them are approved.

What you can answer from here — as of October 25, 2017

3DrugsEach linked to its full drug card

Listed above

12Drug targetsEvery drug–target pair in the class, with bond type

52Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.